Xylocaine Injection, Solution
Product Images NDC 0404-9975

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 0404-9975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of lidocaine hydrochloride, the active ingredient in Xylocaine injection solution. The structure features a benzene ring with two methyl groups, an amide linkage, and a diethylamino group attached to an ethyl chain, paired with a hydrochloride (HCl) molecule.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram of Lidocaine hydrochloride, epinephrine bitartrate injection, solution showing a benzene ring with hydroxyl groups and side chains, representing the active ingredient's molecular configuration.*

FDA Label Image

Image1.jpg (Image1)

A table classifying various drug classes with examples for each. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, listing representative medications such as lidocaine under Local anesthetics, and cyclephosphamide under Antineoplastic agents.*

FDA Label Image

Image2.jpg (Image2)

A dosage guideline table for Xylocaine (lidocaine hydrochloride) injection without epinephrine. It lists various procedures such as infiltration, peripheral nerve blocks, paracervical, sympathetic nerve blocks, and central neural blocks with corresponding concentration percentages, volume in mL, and total dose in mg.*

FDA Label Image

Image3.jpg (Image3)

A table listing product codes, unit of sale, concentration strengths, and vial sizes for Xylocaine (lidocaine HCl injection, USP). The table includes multiple strengths (0.5%, 1%, and 2%) with corresponding dosage in mg/mL and vial sizes ranging from 10 mL to 50 mL, mostly in multiple dose vials.*

FDA Label Image

Image4.jpg (Image4)

A data table presenting product codes, unit of sale, strength, and packaging details for various strengths and vial sizes of Xylocaine (lidocaine hydrochloride injection, USP). The table lists multiple entries with units ranging from 2 mL to 50 mL in single-dose vials and plastic ampules, showing strengths from 0.5% to 2% concentration.*

FDA Label Image

Image5.jpg (Image5)

Data tables listing various product codes, units of sale, strengths, and vial sizes for Xylocaine (lidocaine HCl and epinephrine injection, USP) with epinephrine concentrations of 1:100,000 and 1:200,000. The strengths range from 0.5% to 2%, with corresponding vial sizes of 10 mL, 20 mL, and 50 mL multiple dose vials.*

FDA Label Image

Image6.jpg (Image6)

A data table listing various product codes, units of sale, strengths, and packaging forms for Xylocaine-MPF (lidocaine HCl and epinephrine injection). Strengths include 1%, 1.5%, and 2%, with package sizes from 5 to 25 units and vial volumes of 10 mL, 20 mL, and 30 mL single dose vials.*

FDA Label Image

Label1.jpg (Label1)

Label for Xylocaine 0.5% injection solution containing lidocaine hydrochloride and epinephrine bitartrate 1:200,000, with a concentration of 5 mg/mL in a 50 mL multiple-dose vial. The label includes dosing, storage instructions, cautions, and manufacturer details for Henry Schein, Inc. NDC 0404-9975-56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.